Welcome to the 7th Microbiome Movement - Drug Development Summit Europe

From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel to industry rapidly forward, expanding across a wide range of diseases. With more indications being pursued, and more trials being run than ever before, our ability as a community to overcome outstanding challenges around safety, delivery and commercialisation will define the next stage of microbiome drugs.

Returning in London in January, the 7th Microbiome Movement- Drug Development Summit Europe will unite Europe’s leading drug developers and microbiome experts as they share their latest discoveries on microbiome functionality, translation, clinical development, biomarker discovery and manufacturing scale-up. As we return face-to-face, the 2023 summit will foster collaboration among clinicians, researchers, and industry.

Don’t miss this opportunity to get together in person form vital partnerships that can turn microbiome science into business!

40+ Expert Speakers Including:

Chrysi Sergaki

Microbiome Group Leader

PhD, Principal Investigator - Microbiome Group Leader, MHRA

Elran Haber

Chief Executive Officer


Hervé Affagard


MaaT Pharma

James McIlroy

Founder & Chief Executive Officer


Eric Gálvez

Roche Postdoctoral Fellow (RPF) in Microbiome and Human Genetics


Isabelle De Cremoux

Chief Executive Officer, Chairman & Director - Life Sciences

Seventure Partners

Kristin Wannerberger

Director R&D Alliance Management

Ferring International Center SA

Hear What Our Customers Say

"We need to combine our efforts to accelerate the knowledge and translation into the clinic, and the Microbiome Movement is offering exactly what we are needing."

- Institut Gustave Roussy

"In a field with many conferences of varying quality, the Microbiome Drug Development Summit consistently delivers substantive and compelling conversations and a collaborative vibe"

Celcius Therapeutics

Other Events In The Series